Full Breakdown
FDA Withdraws Proposal for Asbestos Testing in Talc-Based Cosmetics
11/27/2025, 2:40:42 AM
Overview of the FDA's Decision
On November 28, 2025, the Food and Drug Administration (FDA) announced the withdrawal of a proposed rule that aimed to establish standardized testing methods for detecting asbestos in talc-containing cosmetics. This decision, attributed to the Trump administration, comes in response to the requirements set forth by the Modernization of Cosmetics Regulation Act of 2022, which mandated the FDA to develop such testing protocols. The agency cited "good cause" for the withdrawal, referencing complex scientific and legal considerations surrounding asbestos testing.
Implications of Asbestos Exposure
Asbestos is a known carcinogen linked to serious health issues, including mesothelioma, lung cancer, and asbestosis. The FDA's decision raises significant public health concerns, as talc is commonly used in cosmetics for its texture and moisture-absorbing properties. The Environmental Working Group (EWG) has highlighted that nearly 15% of talc-based cosmetic samples tested in 2020 contained asbestos, underscoring the risks associated with these products. Experts warn that even minimal exposure to asbestos can lead to severe health consequences years later.
Official Statements & Responses
Scott Faber, Senior Vice President for Government Affairs at EWG, criticized the FDA's withdrawal, stating, “It’s hard to imagine … that this administration is so dedicated to making Americans less healthy, not more healthy, that they’re withdrawing a rule designed to protect us from asbestos.” The FDA's notice indicated that it would reconsider the best methods for addressing asbestos exposure and would issue a new proposed rule in the future.
Criticism & Opposition
The withdrawal has faced backlash from health advocates and organizations like the EWG, which argue that the decision is irresponsible and endangers public health. They assert that the lack of standardized testing for asbestos in talc-based cosmetics exposes consumers to unnecessary risks. The EWG has long advocated for stringent testing protocols, emphasizing that the cosmetics industry has been aware of the potential for asbestos contamination since the 1950s.
Conflicting Reports & Gaps
While the FDA's notice suggests that the withdrawal is based on a need for further consideration of testing methods, critics argue that this move undermines consumer safety. The agency has not clarified what specific changes may be proposed in the future, leaving uncertainty regarding the timeline and nature of any new regulations.
What's Next
The FDA is expected to issue a separate proposed rule to fulfill its obligations under the 2022 law requiring testing for asbestos in talc-containing cosmetics. The timeline for this new proposal remains unclear, and stakeholders are awaiting further details on how the agency plans to address the public health risks associated with asbestos exposure in cosmetic products.
